Pfizer Falls on Downbeat Guidance as Company Braces for Covid Vaccine Drop-Off
Text size Pfizer said it expects Covid-19 vaccine sales to drop to $13.5 billion in 2023. Mario Tama/Getty Images Pfizer on Tuesday laid out guidance for the 2023 fiscal year well below Wall Street consensus figures, tempering investor expectations ahead of what it expects to be a steep drop in Covid-19 product sales. Shares fell … Read more